INCT OncoTTGen

O INCT OncoTTGen é dedicado ao desenvolvimento de tecnologias inovadoras em oncologia, com foco em terapias gênicas, siRNA, CRISPR e pesquisas translacionais.

Conheça nosso Site:

oncottgen.com
oncottgen.com

Publicações

Buthionine sulfoximine acts synergistically with doxorubicin as a sensitizer molecule on different tumor cell lines: Journal of Toxicology and Environmental Health, Part A: Vol 88 , No 10 - Get Access
Buthionine sulfoximine acts synergistically with doxorubicin as a sensitizer molecule on different tumor cell lines: Journal of Toxicology and Environmental Health, Part A: Vol 88 , No 10 - Get Access
Application of nanoformulations as a strategy to optimize chemotherapeutic treatment of glioblastoma: a systematic review: Journal of Toxicology and Environmental Health, Part B: Vol 27 , No 4 - Get Access
Application of nanoformulations as a strategy to optimize chemotherapeutic treatment of glioblastoma: a systematic review: Journal of Toxicology and Environmental Health, Part B: Vol 27 , No 4 - Get Access

View on mobile